Rationale and Dose Regimen for Sitagliptin/ Glimepiride Combination Therapy in Type 2 Diabetes Treatment. Indian Journal of Forensic Medicine & Toxicology, [S. l.], v. 15, n. 3, p. 4396–4403, 2021. DOI: 10.37506/ijfmt.v15i3.15981. Disponível em: https://www.medicopublication.com/index.php/ijfmt/article/view/15981. Acesso em: 2 jul. 2026.